HUGE — FSD Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- CA$25.47m
- CA$20.66m
- 16
- 28
- 24
- 11
Annual cashflow statement for FSD Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | Final | Final | Final | Final |
| Net Income/Starting Line | -39.2 | -28.5 | -33.9 | -26.7 | -18.2 |
| Depreciation | |||||
| Non-Cash Items | 24.5 | 4.61 | 6.26 | 0.956 | 3.26 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.39 | 0.807 | 2.89 | -7.12 | 1.64 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -13.7 | -19.1 | -20.7 | -28.3 | -10.8 |
| Capital Expenditures | -0.696 | 0 | -0.5 | -0.364 | 0 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.465 | 6.51 | 0.769 | 12.5 | -0.27 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.231 | 6.51 | 0.269 | 12.1 | -0.27 |
| Financing Cash Flow Items | -0.025 | — | 0 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.02 | 24.2 | 38.2 | -2.07 | -3.13 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -9.95 | 11.6 | 17.7 | -18.3 | -14.2 |